Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Neoplasms of the CNS

  Free Subscription


16.04.2018

2 Acta Neuropathol
1 Am J Clin Oncol
1 J Neurochem
5 J Neurooncol
1 J Neurosurg
2 Neuro Oncol
1 Pediatr Hematol Oncol
1 Pediatr Neurosurg
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neuropathol

  1. KATZ LM, Hielscher T, Liechty B, Silverman J, et al
    Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence.
    Acta Neuropathol. 2018 Apr 7. pii: 10.1007/s00401-018-1844.
    PubMed     Text format     Abstract available

  2. PHI JH, Park AK, Lee S, Choi SA, et al
    Genomic analysis reveals secondary glioblastoma after radiotherapy in a subset of recurrent medulloblastomas.
    Acta Neuropathol. 2018 Apr 11. pii: 10.1007/s00401-018-1845.
    PubMed     Text format     Abstract available


    Am J Clin Oncol

  3. RYDZEWSKI NR, Khan AJ, Strauss JB, Chmura SJ, et al
    Mortality After Stereotactic Radiosurgery for Brain Metastases and Implications for Optimal Utilization: A National Cancer Database Study.
    Am J Clin Oncol. 2018 Apr 10. doi: 10.1097/COC.0000000000000441.
    PubMed     Text format     Abstract available


    J Neurochem

  4. CHUMAKOVA A, Lathia JD
    Outlining involvement of stem cell program in regulation of O6-methylguanine DNA methyltransferase and development of temozolomide resistance in glioblastoma: An Editorial Highlight for 'Transcriptional control of O(6) -methylguanine DNA methyltransfe
    J Neurochem. 2018;144:688-690.
    PubMed     Text format     Abstract available


    J Neurooncol

  5. SUNG S, Lee SW, Kwak YK, Kang JH, et al
    Intracranial control and survival outcome of tyrosine kinase inhibitor (TKI) alone versus TKI plus radiotherapy for brain metastasis of epidermal growth factor receptor-mutant non-small cell lung cancer.
    J Neurooncol. 2018 Apr 11. pii: 10.1007/s11060-018-2861.
    PubMed     Text format     Abstract available

  6. MURSCH K
    Information needs and requirements in patients with brain tumours.
    J Neurooncol. 2018 Apr 10. pii: 10.1007/s11060-018-2864.
    PubMed     Text format    

  7. COLEMAN N, Michalarea V, Alken S, Rihawi K, et al
    Safety, efficacy and survival of patients with primary malignant brain tumours (PMBT) in phase I (Ph1) trials: the 12-year Royal Marsden experience.
    J Neurooncol. 2018 Apr 10. pii: 10.1007/s11060-018-2847.
    PubMed     Text format     Abstract available

  8. ONKEN J, Staub-Bartelt F, Vajkoczy P, Misch M, et al
    Acceptance and compliance of TTFields treatment among high grade glioma patients.
    J Neurooncol. 2018 Apr 11. pii: 10.1007/s11060-018-2858.
    PubMed     Text format     Abstract available

  9. GUI C, Kosteniuk SE, Lau JC, Megyesi JF, et al
    Tumor growth dynamics in serially-imaged low-grade glioma patients.
    J Neurooncol. 2018 Apr 9. pii: 10.1007/s11060-018-2857.
    PubMed     Text format     Abstract available


    J Neurosurg

  10. VOGELBAUM MA, Brewer C, Barnett GH, Mohammadi AM, et al
    First-in-human evaluation of the Cleveland Multiport Catheter for convection-enhanced delivery of topotecan in recurrent high-grade glioma: results of pilot trial 1.
    J Neurosurg. 2018 Apr 13:1-10. doi: 10.3171/2017.10.JNS171845.
    PubMed     Text format     Abstract available


    Neuro Oncol

  11. PARK JW, Wollmann G, Urbiola C, Fogli B, et al
    Sprouty2 enhances the tumorigenic potential of glioblastoma cells.
    Neuro Oncol. 2018 Feb 23. pii: 4904223. doi: 10.1093.
    PubMed     Text format     Abstract available

  12. CARUSO H, Heimberger AB
    Comment on "Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma".
    Neuro Oncol. 2018 Apr 10. pii: 4965825. doi: 10.1093.
    PubMed     Text format    


    Pediatr Hematol Oncol

  13. HOLLAND AA, Colaluca B, Bailey L, Stavinoha PL, et al
    Impact of attention on social functioning in pediatric medulloblastoma survivors.
    Pediatr Hematol Oncol. 2018 Apr 13:1-14. doi: 10.1080/08880018.2018.1440333.
    PubMed     Text format     Abstract available


    Pediatr Neurosurg

  14. VESCOVI MC, Bagatto D, Capo G, Maieron M, et al
    A Multimodal Approach to the Treatment of Intraparenchymal Meningioma in a 7-Year-Old Boy: A Case Report.
    Pediatr Neurosurg. 2018 Apr 12. pii: 000487808. doi: 10.1159/000487808.
    PubMed     Text format     Abstract available


    PLoS One

  15. GE Y, Zhong Y, Ji G, Lu Q, et al
    Preparation and characterization of Fe3O4@Au-C225 composite targeted nanoparticles for MRI of human glioma.
    PLoS One. 2018;13:e0195703.
    PubMed     Text format     Abstract available

  16. BLANC-DURAND P, Van Der Gucht A, Schaefer N, Itti E, et al
    Automatic lesion detection and segmentation of 18F-FET PET in gliomas: A full 3D U-Net convolutional neural network study.
    PLoS One. 2018;13:e0195798.
    PubMed     Text format     Abstract available

  17. AL-SERORI H, Ferk F, Kundi M, Bileck A, et al
    Mobile phone specific electromagnetic fields induce transient DNA damage and nucleotide excision repair in serum-deprived human glioblastoma cells.
    PLoS One. 2018;13:e0193677.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: